PharmaTher Believes Ketamine Could Treat This Rare Neurological Condition
The company is also exploring if ketamine can treat other neurological conditions, including Parkinson’s Disease, ALS, and CRPS.
Day: November 24, 2021
Sena Maria On The Benefits of Microdosing
In this episode, Sena Maria gives us an overview of her Microdosing Activation program and explains some of the benefits of microdosing.
Doug Drysdale On How CYB-003 Is Better Than Psilocybin
In this episode, James Hallifax from the Psychedelic Investor, interviews Doug Drysdale, CEO of Cybin (NYSE: CYBN). In this fantastic discussion, Doug and James discuss the potential for psilocybin (magic mushrooms) to treat depression and other mental health issues.
How the COVID Pandemic Inspired Wakeful Travel’s Psychedelic Integration Journals
A travel journal company pivots from external trips to those unfolding in the mind, and the psychedelic community is embracing the one-of-a-kind integration workbook with open arms.
End of content
End of content